Fig. 4From: Cuproptosis regulatory genes greatly contribute to clinical assessments of hepatocellular carcinomaCR risk signature holds wide applicable scope. A-J The survival differences between high- and low-CR risk groups in each HCC clinical subgroup. K The nomogram composing of clinical stage and CR risk level for predicting 1, 3, 5-year OSR of HCC patientsBack to article page